Enveric Biosciences, Inc. (ENVB) vs Imunon, Inc. (IMNN)
Enveric Biosciences, Inc. and Imunon, Inc. are both Biotechnology companies. Enveric Biosciences, Inc. and Imunon, Inc. are of similar size ($7.3M and $6.9M). Imunon, Inc. grew revenue faster over the last twelve months: 0.00% against −13.9%. Across the 13 metrics below, Enveric Biosciences, Inc. leads on 10 and Imunon, Inc. on 3.
Valuation
Profitability
| Metric | ENVB | IMNN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (235.48%) | (641.02%) | (57.72%) |
| Return on assets | (193.53%) | (123.93%) | (49.22%) |
| Return on invested capital | 0.00% | (324.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack